82.47
Healthequity Inc stock is traded at $82.47, with a volume of 958.00K.
It is up +0.45% in the last 24 hours and up +9.15% over the past month.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
See More
Previous Close:
$82.10
Open:
$82.43
24h Volume:
958.00K
Relative Volume:
0.98
Market Cap:
$6.97B
Revenue:
$1.31B
Net Income/Loss:
$215.20M
P/E Ratio:
33.49
EPS:
2.4627
Net Cash Flow:
$408.32M
1W Performance:
+3.64%
1M Performance:
+9.15%
6M Performance:
-14.24%
1Y Performance:
-8.56%
Healthequity Inc Stock (HQY) Company Profile
Name
Healthequity Inc
Sector
Industry
Phone
801-727-1000
Address
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY vs VEEV, BTSG, TEM, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HQY
Healthequity Inc
|
82.47 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
VEEV
Veeva Systems Inc
|
178.11 | 29.44B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
44.82 | 8.32B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
TEM
Tempus Ai Inc
|
46.76 | 8.73B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
WAY
Waystar Holding Corp
|
24.14 | 4.61B | 1.10B | 112.09M | 283.19M | 0.6096 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Downgrade | Goldman | Neutral → Sell |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| May-22-25 | Resumed | RBC Capital Mkts | Outperform |
| Mar-25-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Apr-02-24 | Reiterated | JP Morgan | Overweight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-21-22 | Upgrade | Goldman | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-12-22 | Initiated | Goldman | Sell |
| Apr-11-22 | Initiated | Wells Fargo | Overweight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Mar-30-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-07-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-09-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Jul-02-21 | Initiated | Stephens | Overweight |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Jan-07-21 | Initiated | BTIG Research | Neutral |
| Dec-08-20 | Reiterated | Barrington Research | Outperform |
| Dec-02-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-23-20 | Downgrade | Guggenheim | Buy → Neutral |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-14-20 | Initiated | Guggenheim | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Mar-17-20 | Reiterated | Barrington Research | Outperform |
| Oct-07-19 | Initiated | Goldman | Neutral |
| Sep-09-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jul-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-05-19 | Reiterated | BofA/Merrill | Neutral |
| Mar-01-19 | Reiterated | BofA/Merrill | Neutral |
| Feb-07-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-07-19 | Upgrade | SunTrust | Hold → Buy |
| Dec-06-18 | Downgrade | SunTrust | Buy → Hold |
| Sep-06-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| May-23-18 | Initiated | BofA/Merrill | Buy |
| Apr-24-18 | Resumed | JP Morgan | Overweight |
| Mar-20-18 | Reiterated | Chardan Capital Markets | Buy |
| Dec-06-17 | Reiterated | Chardan Capital Markets | Buy |
View All
Healthequity Inc Stock (HQY) Latest News
Published on: 2026-03-25 19:47:51 - baoquankhu1.vn
Congress Asset Management Co. Buys 27,102 Shares of HealthEquity, Inc. $HQY - MarketBeat
HealthEquity: Can Deeper Employer Integration and Digital Engagement Drive the Next Wave of HSA Adoption? - Smartkarma
HealthEquity, Inc. (NASDAQ:HQY) Q4 2026 earnings call transcript - MSN
HealthEquity Inc stock faces pressure amid insider sales and GLP-1 platform launch on NASDAQ - AD HOC NEWS
One company’s million-dollar gambit to turn the healthcare crisis into a gold mine - Popular Information | Judd Legum
HealthEquity analysts cut their forecasts after Q4 results - MSN
HealthEquity Chases $100b Market With Record HSA Growth And New Platform - Yahoo Finance
HealthEquity Inc stock faces scrutiny amid slowing HSA growth and rising competition in US benefits - AD HOC NEWS
HealthEquity Q4 Earnings Rise; Raises 2027 Outlook - Value The Markets
CIBC Private Wealth Group Reduces HealthEquity Stake - National Today
HealthEquity price target raised to $128 from $120 at Deutsche Bank - TipRanks
HealthEquity Analysts Cut Their Forecasts After Q4 Results - Sahm
HQY: Deutsche Bank Raises Price Target, Maintains Buy Rating | H - GuruFocus
HealthEquity (NASDAQ:HQY) Price Target Raised to $128.00 at Deutsche Bank Aktiengesellschaft - MarketBeat
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY) and Intuitive Surgical (ISRG) - The Globe and Mail
HealthEquity, Inc. (NASDAQ:HQY) Q4 2026 Earnings Call Transcript - Insider Monkey
Discipline and Rules-Based Execution in HQY Response - Stock Traders Daily
Deutsche Bank Adjusts HealthEquity Price Target to $128 From $120, Maintains Buy Rating - marketscreener.com
Analysts’ Top Healthcare Picks: Healthequity (HQY), AbSci (ABSI) - The Globe and Mail
BMO Maintains Market Perform on HealthEquity (HQY) March 18, 2026 - Meyka
HealthEquity Inc. Earnings Call Highlights Profitable Growth - TipRanks
Reasons to hold HealthEquity stock in your portfolio for now - MSN
HealthEquity (HQY) Margin Expansion To 16.4% Tests Bearish Cost Narratives - simplywall.st
HealthEquity Q4 Earnings Call Highlights - MarketBeat
New health sharing program has seen 236% growth rate, with high hopes for 2026 - AOL.com
HealthEquity (HQY): Analyst Lowers Price Target Amid Maintained Rating | HQY Stock News - GuruFocus
JP Morgan Maintains Rating, Lowers Price Target for HealthEquity (HQY) | HQY Stock News - GuruFocus
HealthEquity stock price target lowered to $100 by RBC on yield outlook By Investing.com - Investing.com India
JPMorgan Chase & Co. Issues Pessimistic Forecast for HealthEquity (NASDAQ:HQY) Stock Price - MarketBeat
HealthEquity (NASDAQ:HQY) Given New $110.00 Price Target at Barrington Research - MarketBeat
HQY: RBC Capital Maintains Outperform Rating, Lowers Price Targe - GuruFocus
HealthEquity, Inc. 2026 Annual Report: Technology-Driven HSA Solutions, Competitive Strategy, AI Innovation, and Risk Factors 232527293940 - Minichart
HealthEquity stock price target lowered to $100 by RBC on yield outlook - Investing.com South Africa
BMO reiterates HealthEquity stock rating on strong quarter, AI progress - Investing.com UK
BMO reiterates HealthEquity stock rating on strong quarter, AI progress By Investing.com - Investing.com Australia
Royal Bank Of Canada Has Lowered Expectations for HealthEquity (NASDAQ:HQY) Stock Price - MarketBeat
HealthEquity, Inc. Q4 2026 Earnings Call Summary - Yahoo Finance
HealthEquity (HQY) Q4 EPS Plunges 42.6% YoY to $0.95, Misses Estimates Despite $334.6M Revenue Beat - AlphaStreet
RBC Cuts Price Target on HealthEquity to $100 From $110, Keeps Outperform Rating - marketscreener.com
Faithward Advisors Boosts HealthEquity Stake to $4.41 Million - National Today
Faithward Advisors LLC Takes $4.41 Million Position in HealthEquity, Inc. $HQY - MarketBeat
HQY SEC FilingsHealthequity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Crown Advisors Management Inc. Invests $1.90 Million in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity: Fiscal Q4 Earnings Snapshot - theheraldreview.com
HealthEquity: Attractive Given Improved Cash Economics (Rating Upgrade) - Seeking Alpha
Healthequity Inc earnings beat by $0.05, revenue topped estimates - Investing.com Australia
HealthEquity (HQY) beats Q4 earnings and revenue estimates - MSN
Decoding HealthEquity Inc (HQY): A Strategic SWOT Insight - GuruFocus
HealthEquity Inc (HQY) Q4 2026 Earnings Call Highlights: Record HSA Growth and Strong Financial ... By GuruFocus - Investing.com Canada
Healthequity Inc Stock (HQY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):